Abstract

Milrinone 0.2-mg/mL Injection

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2013 - Volume 17, Number 1

Page(s): 69

Download in electronic PDF format for $75
  • Milrinone 0.2-mg/mL Injection Page 1

Abstract

A formulation for preparing Milrinone 0.2-mg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • milrinone lactate
  • formulation
  • phosphodiesterase type-3 inhibitor
  • congestive heart failure
  • calcium antagonist intoxication
  • cardiac contractility
  • vasodilation
  • vasodilator

Related Categories

  • FORMULATIONS
  • PARENTERALS
  • STERILE PREPARATIONS
  • CARDIOLOGY
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2013
Pg. 69
Milrinone 0.2-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2009
Pg. 367-371
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret
Author(s): Williams LaVonn A, Riley Kari
Mar/Apr 1998
Pg. 168-169
Stability of Milrinone Lactate 200 mcg/mL in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Author(s): Wong Frances, Gill Mark A
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Sep/Oct 2008
Pg. 460-462
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration
Author(s): Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
May/Jun 1998
Pg. 246-248
Stability of Milrinone Lactate in 5% Dextrose Injection and 0.9% Sodium Chloride Injection at Concentrations of 400, 600, 800 mcg/mL
Author(s): Nguyen Dana, Gill Mark A, Wong Frances
Mar/Apr 2010
Pg. 108-111
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Author(s): Bramwell Bethany L
Nov/Dec 2006
Pg. 457
Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 333
Metoprolol Tartrate 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 419
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2007
Pg. 422
Ergonovine Maleate 0.2-mg/mL Injection, Veterinary
Author(s): Allen Loyd V Jr
Nov/Dec 2009
Pg. 554
Cidofovir 0.2-mg/mL Intravitreous Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2017
Pg. 320
Torsemide 10-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2019
Pg. 148
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2010
Pg. 157
Metolazone 10-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2012
Pg. 419
Enalaprilat 1.25-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2006
Pg. 227
Quinapril 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 494
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
Author(s): Allen Loyd V Jr
Nov/Dec 2017
Pg. 496
Spironolactone 5 mg/mL in SuspendIt Oral Suspension
Author(s): Allen Loyd V Jr